MAZE – maze therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MAZE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/25

10:32 am

maze

Maze Therapeutics, Inc. (NASDAQ: MAZE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $19.00 price target on the stock.

Medium Report

Maze Therapeutics, Inc. (NASDAQ: MAZE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $19.00 price target on the stock.

Report

2/25

10:32 am

maze

Maze Therapeutics, Inc. (NASDAQ: MAZE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $19.00 price target on the stock.

Medium Report

Maze Therapeutics, Inc. (NASDAQ: MAZE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $19.00 price target on the stock.

Report

2/25

09:54 am

maze

Rating for MAZE

Medium Report

Rating for MAZE

Report

2/25

09:54 am

maze

Rating for MAZE

Medium Report

Rating for MAZE

Report

2/25

08:00 am

maze

Maze Therapeutics, Inc. (NASDAQ: MAZE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $30.00 price target on the stock.

Medium Report

Maze Therapeutics, Inc. (NASDAQ: MAZE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $30.00 price target on the stock.

Report

2/25

08:00 am

maze

Maze Therapeutics, Inc. (NASDAQ: MAZE) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $28.00 price target on the stock.

Medium Report

Maze Therapeutics, Inc. (NASDAQ: MAZE) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $28.00 price target on the stock.

Report

2/25

07:43 am

maze

Rating for MAZE

Medium Report

Rating for MAZE

Report

2/25

06:07 am

maze

Maze Therapeutics initiated with an Outperform at Leerink

Medium Report

Maze Therapeutics initiated with an Outperform at Leerink

Report

2/25

05:37 am

maze

Rating for MAZE

Medium Report

Rating for MAZE

Report

2/25

05:06 am

maze

Maze Therapeutics initiated with an Overweight at JPMorgan

Medium Report

Maze Therapeutics initiated with an Overweight at JPMorgan

Report

2/25

04:55 am

maze

Maze Therapeutics initiated with a Buy at Guggenheim

Medium Report

Maze Therapeutics initiated with a Buy at Guggenheim

Report

2/25

04:55 am

maze

Maze Therapeutics initiated with a Buy at Guggenheim

Medium Report

Maze Therapeutics initiated with a Buy at Guggenheim

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.